Antibiotics form the first line of defense against all sorts of diseases that affect human beings. This is why their development is given such high priority in the field of medical research.
Initially, most of these antibiotics were derived from bacteria found in soil and fungi, but in recent years that has become a rare occurrence.
This has put a lot of stress on the current strains of antibiotics to deal with a plethora of diseases that require different types of treatments.
As if to add fuel on fire, the diseases being treated with these existing antibiotics seem to have started developed their own defense mechanisms against medical treatments.
This cycle of misfortune has now brought us to a stage where the disease are more powerful than the treatment, thus making doctors and researchers worry about new outbreaks of deadly diseases.
What we need in this scenario is a new type of antibiotic that can fight these new strains of drug resistant diseases for us, and we seem to have found it in the unlikeliest of places.
What we are hinting at is a new type of bacterium called Staphylococcus Lugdunensis that’s recently been discovered inside the human nose.
This bacterium was discovered during a study that took swab tests from over 90 patients, and has already been used to create a new drug called Lugdunin.
This drug has been tested and proven to work against MRSA in mice. MRSA is a known superbug, and the success of this drug against it gives hope that we may have stumbled onto a new resource for medical treatments which can possibly treat various other types of drug resistant diseases.
The credit for this discovery goes to researchers from the University of Tübingen in Germany, who are even now working on making this drug secure for human use.